Clinical Trial Update: Study of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in Asia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating TAS-102 (trifluridine/tipiracil) in metastatic colorectal cancer in Asia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2020-11-17